Evidence map›Paper›PMID 24845637›Full record

ArticleInvestigative ophthalmology & visual science2014

STAT6-mediated keratitis and blepharitis: a novel murine model of ocular atopic dermatitis.

Matthew J Turner, Sonia DaSilva-Arnold, Na Luo, Xinyao Hu, Callah C West, Lou Sun, Christopher Hill, Joshua Bradish, Mark H Kaplan, Jeffrey B Travers and 1 more

Erratum issuedOpen access · bronzeAbstract read
In one paragraph

Article in Investigative ophthalmology & visual science, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.9field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. The STAT6 inhibitor AS1517499 reduces the risk of asthma in mice with 2,4-dinitrochlorobenzene-induced atopic dermatitis by blocking the STAT6 signaling pathway.Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology · 2022
    Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Matthew J TurnerDepartment of Dermatology, Indiana University, Indianapolis, Indiana, United States Richard L. Roudebush VA Medical Center, Indianapolis, Indiana, Unites States.
Sonia DaSilva-ArnoldDepartment of Dermatology, Indiana University, Indianapolis, Indiana, United States.
Na LuoEugene and Marilyn Glick Eye Institute, Department of Ophthalmology, Indiana University, Indianapolis, Indiana, United States.
Xinyao HuEugene and Marilyn Glick Eye Institute, Department of Ophthalmology, Indiana University, Indianapolis, Indiana, United States.
Callah C WestEugene and Marilyn Glick Eye Institute, Department of Ophthalmology, Indiana University, Indianapolis, Indiana, United States.
Lou SunEugene and Marilyn Glick Eye Institute, Department of Ophthalmology, Indiana University, Indianapolis, Indiana, United States.
Christopher HillEugene and Marilyn Glick Eye Institute, Department of Ophthalmology, Indiana University, Indianapolis, Indiana, United States.
Joshua BradishDepartment of Pathology, Indiana University, Indianapolis, Indiana, United States.
Mark H KaplanDepartment of Pediatrics, Indiana University, Indianapolis, Indiana, United States.
Jeffrey B TraversDepartment of Dermatology, Indiana University, Indianapolis, Indiana, United States Richard L. Roudebush VA Medical Center, Indianapolis, Indiana, Unites States.
Yang SunDepartment of Dermatology, Indiana University, Indianapolis, Indiana, United States Eugene and Marilyn Glick Eye Institute, Department of Ophthalmology, Indiana University, Indianapolis, Indiana, United States.
Indiana University – Purdue University Indianapolis · USRichard L. Roudebush VA Medical Center · US

Funding

Platelet Activating Factor and Epidermic CytotoxicityR01HL062996 · NHLBI · WRIGHT STATE UNIVERSITY · PI TRAVERS, JEFFREY B. · 1999 to 2023
$7.2M
Cytokine regulation of skin barrier functionR01AI095282 · NIAID · INDIANA UNIVERSITY INDIANAPOLIS · PI KAPLAN, MARK H · 2012 to 2022
$4.3M
Glaucoma Pathogenesis of Oculocerebrorenal syndrome of LoweK08EY022058 · NEI · STANFORD UNIVERSITY · PI SUN, YANG · 2012 to 2016
$994k
NEI NIH HHS K08 EY022058NHLBI NIH HHS R01 HL062996NHLBI NIH HHS R01HL062996NIAID NIH HHS R01 AI095282
6 · The paper itself

Abstract

purposeAtopic dermatitis (AD) is a common inflammatory disease that can affect the eye, resulting in ocular pathologies, including blepharitis, keratitis, and uveitis; however, the pathogenic mechanisms underlying the ocular manifestations of AD are not well understood.

methodsIn the present study, we characterized the ocular pathologies that develop in the Stat6VT mouse model of AD. We examined the cytokine profile of the eyelid lesions, measured the behavioral response, and documented the treatment response to topical steroids.

resultsOur results show that Stat6VT mice spontaneously developed blepharitis, keratitis, and uveitis similar to that observed in patients with AD. Histologic findings of allergic inflammation in affected eyelids in this model include the presence of a lymphocyte-predominant infiltrate and tissue eosinophilia in the dermis. Gene expression analysis of affected eyelid tissue by quantitative PCR revealed increased amounts of mRNAs for the Th2 cytokines IL-4, IL-5, and IL-13. In addition, increased eyelid scratching was seen in Stat6VT mice with blepharitis. Topical treatment with the corticosteroid clobetasol reduced eyelid inflammation, tissue eosinophilia, and Th2 cytokine expression.

conclusionsThe development of AD-like ocular pathologies in this model supports the idea that in humans, AD-associated disease of the eye may be driven by Th2-mediated inflammation and demonstrates that the Stat6VT mouse may be a useful system in which to further investigate pathogenesis of and treatment strategies for blepharitis and other ocular diseases that develop in association with AD.

Indexed as

Gene Expression RegulationAnimalsBlepharitisDermatitis, AtopicDisease Models, AnimalImmunoblottingKeratitisMiceMice, TransgenicPolymerase Chain ReactionRNASTAT6 Transcription FactorRNAStat6 protein, mouseSTAT6 Transcription Factoratopic blepharitisocular atopic dermatitisSTAT6

Identifiers

PMID24845637
PMCPMC4062401
OpenAlexW2041080807

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.